CAS RN: 13292-46-1
Rifampicin
Product Availability
Choose a grade to view its available package options.
11 package records11 with current stock3 grade groups
| Batch No. | Package | Availability | Warehouse | Inquiry |
|---|---|---|---|---|
| Batchno.20251004 | 100g | In stock | Shanghai | Inquiry |
| Batchno.20260316 | 10g | In stock | Shanghai | Inquiry |
| Batchno.20251004 | 1g | In stock | Shanghai, Shenzhen, Tianjin | Inquiry |
| Batchno.20260617 | 25g | In stock | Shanghai, Tianjin | Inquiry |
| Batchno.20250123 | 500g | In stock | Shanghai | Inquiry |
| Batchno.20250424 | 5g | In stock | Shanghai, Shenzhen, Tianjin | Inquiry |
| Batch No. | Package | Availability | Warehouse | Inquiry |
|---|---|---|---|---|
| Batchno.20260620 | 1ml | In stock | Inquiry |
- Product code: ICTR0079
- Purity/Analytical Methods: >98.0%(T)
13292-46-1 / [(7S,9E,11S,12R,13S,14R,15R,16R,17S,18S,19E,21Z)-2,15,17,27,29-pentahydroxy-11-methoxy-3,7,12,14,16,18,22-heptamethyl-26-[(E)-(4-methylpiperazin-1-yl)iminomethyl]-6,23-dioxo-8,30-dioxa-24-azatetracyclo[23.3.1.14,7.05,28]triaconta-1(29),2,4,9,19,21,25,27-octaen-13-yl] acetate
Basic Information
CAS
13292-46-1
Multi CAS
No
Molecular Formula
C43H58N4O12
Molecular Weight
822.900000
Exact Mass
822.405123
SMILES
C[C@H]1/C=C/C=C(\C(=O)NC2=C(C(=C3C(=C2O)C(=C(C4=C3C(=O)[C@](O4)(O/C=C/[C@@H]([C@H]([C@H]([C@@H]([C@@H]([C@@H]([C@H]1O)C)O)C)OC(=O)C)C)OC)C)C)O)O)/C=N/N5CCN(CC5)C)/C
InChI
InChI=1S/C43H58N4O12/c1-21-12-11-13-22(2)42(55)45-33-28(20-44-47-17-15-46(9)16-18-47)37(52)30-31(38(33)53)36(51)26(6)40-32(30)41(54)43(8,59-40)57-19-14-29(56-10)23(3)39(58-27(7)48)25(5)35(50)24(4)34(21)49/h11-14,19-21,23-25,29,34-35,39,49-53H,15-18H2,1-10H3,(H,45,55)/b12-11+,19-14+,22-13-,44-20+/t21-,23+,24+,25+,29-,34-,35+,39+,43-/m0/s1
InChIKey
JQXXHWHPUNPDRT-WLSIYKJHSA-N
Physical Properties
Melting Point
Decomposes 183-188 °C
Appearance
Red to orange platelets from acetone
Red-brown crystalline powder
State
Solid
Computed Properties
Structural Parameters
Heavy atom count
59
Aromatic heavy atom count
10
Fraction Csp3
0.53
Rotatable bonds
4
H-bond acceptors
15
H-bond donors
6
Molar refractivity
220.48
TPSA
220.15
LogP / Solubility
WLOGP
4.34
MLOGP
3.89
XLogP3
4.9
Consensus LogP
4.38
Log S (ESOL)
-7.54
Class (ESOL)
Insoluble
Log S (Ali)
-9.44
Class (Ali)
Insoluble
Log S (SILICOS-IT)
-9.09
Class (SILICOS-IT)
Insoluble
ADME
GI absorption
Low
BBB permeant
No
P-gp substrate
Yes
CYP1A2 inhibitor
No
CYP2C19 inhibitor
Yes
CYP2C9 inhibitor
No
CYP2D6 inhibitor
Yes
CYP3A4 inhibitor
Yes
Log Kp (skin permeation)
-4.66
Drug-likeness / Medicinal Chemistry
Lipinski
No
Ghose
No
Veber
No
Egan
No
Muegge
No
Bioavailability score
0.17
PAINS alerts
1
Brenk alerts
1
Leadlikeness
No
Synthetic Accessibility
10
Safety & Transport
Pictogram(s)
Irritant
Signal
Warning
GHS Hazard Statements
H302 (98.4%): Harmful if swallowed [Warning Acute toxicity, oral]
H315 (85.2%): Causes skin irritation [Warning Skin corrosion/irritation]
H319 (85.2%): Causes serious eye irritation [Warning Serious eye damage/eye irritation]
H335 (83.6%): May cause respiratory irritation [Warning Specific target organ toxicity, single exposure; Respiratory tract irritation]
Precautionary Statement Codes
P261, P264, P264+P265, P270, P271, P280, P301+P317, P302+P352, P304+P340, P305+P351+P338, P319, P321, P330, P332+P317, P337+P317, P362+P364, P403+P233, P405, and P501
